Yoon Woo Koh Selected Research

Biomarkers (Surrogate Marker)

10/2022	Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma.
1/2022	Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma.
4/2020	Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma.
4/2020	Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
1/2019	NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma.
2/2016	Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
1/2016	Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.
2/2015	Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoon Woo Koh Research Topics

Disease

35	Neoplasms (Cancer) 04/2023 - 12/2010
17	Squamous Cell Carcinoma of Head and Neck 03/2024 - 03/2012
16	Head and Neck Neoplasms (Head and Neck Cancer) 12/2021 - 03/2012
12	Neoplasm Metastasis (Metastasis) 11/2016 - 01/2012
10	Thyroid Neoplasms (Thyroid Cancer) 06/2022 - 01/2010
7	Carcinoma (Carcinomatosis) 11/2021 - 12/2010
6	Cicatrix (Scar) 04/2020 - 11/2012
6	Intraoperative Complications 01/2016 - 03/2014
5	Papillary Thyroid Cancer 11/2016 - 11/2012
4	Margins of Excision 01/2023 - 08/2012
4	Hemorrhage 04/2020 - 02/2013
3	Mouth Neoplasms (Oral Cancer) 04/2023 - 03/2018
3	Oropharyngeal Neoplasms 01/2023 - 01/2020
3	Parotid Neoplasms 01/2020 - 03/2013
3	Tongue Neoplasms (Tongue Neoplasm) 10/2018 - 01/2012
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 03/2017 - 03/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2016 - 01/2012
3	Lymphatic Metastasis 03/2015 - 12/2012
2	Tonsillar Neoplasms 12/2022 - 01/2019
2	Hypopharyngeal Neoplasms 09/2019 - 05/2015
2	Anaplastic Thyroid Carcinoma 01/2017 - 11/2016
2	Papillary Carcinoma 11/2014 - 12/2012
2	Wounds and Injuries (Trauma) 11/2014 - 03/2013
2	Hematoma 03/2013 - 05/2010
2	Vocal Cord Paralysis 05/2010 - 10/2007
2	Postoperative Pain 03/2009 - 08/2008
1	Mucoepidermoid Carcinoma 10/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Liposarcoma 01/2022
1	Leiomyosarcoma 01/2022
1	Parathyroid Diseases (Parathyroid Disorders) 12/2020
1	Deglutition Disorders (Dysphagia) 12/2018
1	Suppuration 04/2018
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2018
1	Salivary Gland Calculi (Sialolithiasis) 12/2017
1	Hyperemia 01/2017
1	Melanoma (Melanoma, Malignant) 11/2016
1	Hypoxia (Hypoxemia) 11/2015

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2015
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 10/2012
3	Proteins (Proteins, Gene)FDA Link 04/2020 - 07/2014
2	B7-H1 AntigenIBA 09/2021 - 11/2016
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
2	Therapeutic UsesIBA 12/2018 - 11/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018 - 02/2012
2	VemurafenibIBA 01/2017 - 11/2016
2	dacomitinibIBA 01/2016 - 02/2015
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2015 - 03/2015
2	Capsules (Microcapsules)IBA 12/2012 - 08/2012
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2011 - 12/2010
1	durvalumabIBA 03/2024
1	tremelimumabIBA 03/2024
1	eribulin FDA Link 01/2022
1	Gemcitabine FDA Link 01/2022
1	poliovirus receptorIBA 09/2021
1	NVP-BKM120IBA 12/2020
1	Cetuximab (Erbitux)FDA Link 12/2020
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 04/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	PD 173074IBA 12/2018
1	AZD 6244IBA 12/2018
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 12/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2018
1	C-Reactive ProteinIBA 04/2018
1	Contrast MediaIBA 01/2018
1	gadobutrolIBA 01/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018
1	GadoliniumIBA 01/2018
1	Plasma GasesIBA 03/2017
1	GasesIBA 03/2017
1	diclofenac hydroxyethylpyrrolidine (DIEP)FDA Link 01/2017
1	ErbB Receptors (EGF Receptor)IBA 02/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	RacivirIBA 11/2015

Therapy/Procedure

28	Neck Dissection (Radical Neck Dissection) 06/2022 - 03/2008
16	Thyroidectomy 06/2022 - 03/2008
14	Rhytidoplasty (Facelift) 12/2020 - 10/2011
10	Radiotherapy 05/2024 - 01/2012
8	Length of Stay 04/2020 - 07/2011
7	Therapeutics 01/2023 - 10/2012
4	Free Tissue Flaps 04/2023 - 01/2012
4	Lymph Node Excision (Lymph Node Dissection) 04/2020 - 12/2012
3	Immunotherapy 03/2024 - 01/2020
3	Adjuvant Radiotherapy 01/2022 - 10/2018
3	Conversion to Open Surgery 01/2016 - 03/2014
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2012
2	Surgical Instruments (Clip) 12/2017 - 08/2008
2	Operative Time 03/2014 - 03/2012
2	Laryngoplasty 05/2010 - 10/2007
1	Precision Medicine 10/2022
1	Endoscopes 12/2021
1	Neoadjuvant Therapy 11/2021
1	Parathyroidectomy 12/2020
1	Laryngectomy 12/2018
1	Salvage Therapy 12/2018
1	Chemoradiotherapy 10/2018
1	Aftercare (After-Treatment) 10/2018
1	Induction Chemotherapy 01/2016